Neogen Corporation (NEOG) Social Stream



Neogen Corporation (NEOG): $20.04

0.16 (+0.80%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NEOGEN CORP (NEOG) Price Targets From Analysts

Use the tables below to see what analysts covering NEOGEN CORP think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-07-12 2 $25 $25 $25 $19.88 25.75%
2022-08-01 2 $26 $26 $26 $19.88 30.78%
2022-08-30 2 $20 $20 $20 $19.88 0.6%
2022-10-10 2 $14 $14 $14 $19.88 -29.58%
2022-12-14 2 $17 $17 $17 $19.88 -14.49%
2023-01-20 2 $20 $20 $20 $19.88 0.6%
NA 1 $NA $NA $NA $19.88 NA%

The Trend in the Analyst Price Target


NEOG's average price target has moved down $67.5 over the prior 20 months.

Over the past 27 weeks, NEOG's average upside potential has been 8.04%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-01 2 26 26 26 22.58 15.15%
2022-08-30 2 20 20 20 21.17 -5.53%
2022-10-10 2 14 14 14 12.11 15.61%
2022-12-14 2 17 17 17 15.35 10.75%
2023-01-20 2 20 20 20 19.62 1.94%

NEOG Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 1 0 1 0 0 2

The Trend in the Broker Recommendations


Over the past 31 days, NEOG's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NEOG as an investment opportunity.

  • NEOGEN CORP's number of analysts covering the stock is greater than 17.15% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, NEOGEN CORP's variance in analysts' estimates is lower than nearly 100% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, NEOGEN CORP's upside potential (average analyst target price relative to current price) is higher than 56.16% of them.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, NEOGEN CORP's average analyst price target is higher than 131.41% of them.

Stocks similar to NEOGEN CORP in the Pharmaceutical Products industry regarding analyst recommendations and price targets are EVO, ZNTL, and SDGR.

What is the outlook for NEOG? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7438 seconds.